Search Drug Information, Interactions, Images, Dosage & Side Effects

No CV safety signals with fremanezumab treatment for migraine 04 Jun 2020
Patients using the CGRP* blocker fremanezumab for migraine treatment need not worry about cardiovascular (CV) safety of the drug, as pooled data from three phase III trials showed no safety signals for CV events with the treatment, even in those with a CV medical history.

Performance status, not age, predicts nivolumab efficacy, safety in elderly NSCLC patients

04 Jun 2020

Diabetes affects weight loss magnitude after bariatric surgery

04 Jun 2020

Metformin prevents prednisone-induced hyperglycaemia in haematological cancers

04 Jun 2020

Infection risk comparable between biologics, nonbiologics in children with psoriasis

04 Jun 2020

COVID-19 guidelines lack details, neglect vulnerable people

04 Jun 2020

Maternal BMI, glycaemia linked to childhood adiposity

04 Jun 2020

PEEK cages, allografts yield comparable outcomes in two-level ACDF

04 Jun 2020

Adults at high risk of knee arthritis may engage in vigorous activities

04 Jun 2020

Pinch strength predicts mild cognitive impairment in patients with CVD

04 Jun 2020

Metformin counters risks associated with diabetes in NASH cirrhosis patients

04 Jun 2020

Protecting young lives against vaccine preventable diseases (VPDs): The value of combination vaccines in optimizing immunisation schedules and curbing infectious disease transmission 02 Jun 2020;
At a GSK-sponsored symposium during the 15th Asian & Oceanian Congress of Child Neurology 2019, held in conjunction with the 41st Malaysian Paediatric Association Annual Congress at Shangri-La Hotel Kuala Lumpur, Dato’ Dr Musa Mohd Nordin spoke about the current state of VPDs and expounded the value of combination vaccines in mitigating the risk of infectious disease transmission in the paediatric population.